Britain Brazil city Oxford covid-19 testing pandemic vaccine Britain Brazil city Oxford

How AstraZeneca can recover from its covid-19 vaccine stumble

Reading now: 430
www.livemint.com

Covid-19 pandemic now resurgent across the globe, it’s a comfort to know that there are several promising vaccine candidates in speedy development.

Their success is crucial in fighting the virus and charting a path back to normal. It's important, though, that we are able to see rigorous, clean and transparent trial data, to help gain trust in any vaccine and know that proper protocols are in place.

Unfortunately, one of the leading vaccine candidates – from AstraZeneca Plc, working with the University of Oxford — is having a problem in this area.Astra and Oxford released interim data last week from their Covid-19 vaccine trials in the UK and Brazil, becoming the third developers after Moderna Inc.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA